pI: 8.8326 |
Length (AA): 219 |
MW (Da): 24765 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_137759)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_40645 | Hypothetical 35.6 kDa protein ZK1073.1 in chromosome X, putative |
Caenorhabditis elegans | CELE_ZK1073.1 | Protein ZK1073.1 |
Drosophila melanogaster | Dmel_CG2082 | CG2082 gene product from transcript CG2082-RO |
Echinococcus granulosus | EgrG_000947700 | hypothetical protein |
Echinococcus granulosus | EgrG_001065500 | Ndr |
Echinococcus multilocularis | EmuJ_000948500 | Ndr |
Echinococcus multilocularis | EmuJ_000948600 | Ndr |
Echinococcus multilocularis | EmuJ_000948000 | Ndr family protein |
Echinococcus multilocularis | EmuJ_001065500 | Ndr |
Echinococcus multilocularis | EmuJ_000948100 | Ndr |
Echinococcus multilocularis | EmuJ_000947700 | Ndr |
Loa Loa (eye worm) | LOAG_06299 | hypothetical protein |
Schistosoma japonicum | Sjp_0086390 | IPR004142,Ndr,domain-containing |
Schistosoma japonicum | Sjp_0024830 | IPR004142,Ndr,domain-containing |
Schistosoma japonicum | Sjp_0303030 | Protein NDRG4, putative |
Schistosoma mansoni | Smp_000320 | Ndr family |
Schistosoma mansoni | Smp_194720 | family S33 non-peptidase homologue (S33 family) |
Schmidtea mediterranea | mk4.014264.01 | |
Schmidtea mediterranea | mk4.005729.04 | Family S33 non-peptidase homologue |
Schmidtea mediterranea | mk4.019412.01 | BcDNA.GH02439 |
Schmidtea mediterranea | mk4.005770.01 | |
Schmidtea mediterranea | mk4.001370.06 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.